rontalizumab

Ligand id: 9640

Name: rontalizumab

No information available.
Summary of Clinical Use
Clinical development was discontinued after a failure to show efficacy in a Phase 2 clinical trial (NCT00962832) in patients with systemic lupus erythematosus (SLE) [4].